Rose Sharon Shabet, 10% Owner at Urovant Sciences Ltd. (UROV), bought 22,011 shares at $8.30 ($177K) on 2019-06-12, disclosed to the SEC on 2019-06-14.
Scheduled purchase ($177k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.30 | 7,500 | $62K | 35.1% |
| 2 | $7.95 | 7,367 | $59K | 33.0% |
| 3 | $7.91 | 7,144 | $57K | 31.9% |
| Total | $8.06 avg | 22,011 | $177K | 100% |
| Filing → |
| FIGS | SELL | 2021-09-03 | $18.7M | — | Filing → |
| BBIO | BUY | 2019-06-28 | $80.0M | — | Filing → |